2013
DOI: 10.1016/j.jopr.2013.04.008
|View full text |Cite
|
Sign up to set email alerts
|

Amorphous solid dispersion method for improving oral bioavailability of poorly water-soluble drugs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
44
0
1

Year Published

2014
2014
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 48 publications
(45 citation statements)
references
References 19 publications
0
44
0
1
Order By: Relevance
“…Solid dispersion is defined as “The dispersion of one or more active ingredients in an inert carrier matrix at solid-state’’ 3 . There are many methods to prepare solid dispersions such as the fusion method, ball milling, solvent evaporation, lyophilization, hot melt extrusion (HME) and supercritical fluid methods 4, 5 …”
Section: Introductionmentioning
confidence: 99%
“…Solid dispersion is defined as “The dispersion of one or more active ingredients in an inert carrier matrix at solid-state’’ 3 . There are many methods to prepare solid dispersions such as the fusion method, ball milling, solvent evaporation, lyophilization, hot melt extrusion (HME) and supercritical fluid methods 4, 5 …”
Section: Introductionmentioning
confidence: 99%
“…The main disadvantage of the first generation solid dispersions is the high thermodynamic stability of the carrier, which promotes lower dissolution rates compared with amorphous solid dispersions [13,34]. Also, the high melting point of some carriers used in crystalline solid dispersions complicates the preparation of such systems by the melting method [13,14]. Urea, organic acids, and most sugars (mannitol is an exception) are thermally unstable; therefore, they are unsuitable for solid dispersion preparation by the melting method.…”
Section: First-generation Solid Dispersionsmentioning
confidence: 99%
“…The need for effective formulations for BCS-classes II and IV drugs led to the progress of knowledge in the area of drug delivery systems for oral administration, over the years, and to the development of various technological strategies to remedy unsatisfactory biopharmaceutical properties, for example, micronization [8], formation of complexes with cyclodextrins [9], self-emulsifying drug delivery systems (SEDDS) [10], liquisolid systems [11,12] and solid dispersions [13,14].…”
Section: Introductionmentioning
confidence: 99%
“…In addition, specific intermolecular interactions between API and polymer in ASD aid to inhibit nucleation and crystal growth. These benefits of ASD have been exploited as one of the key approaches of oral bioavailability improvement of poorly water soluble drugs …”
Section: Amorphous Solid Dispersionmentioning
confidence: 99%
“…There are very few analytical techniques that offer spatial capability to probe the miscibility at molecular level in complex ASD . This is one of the key hurdles in identifying, at nanoscopic level, whether API molecules are dispersed at molecular level (glass solution), present as amorphous clusters (amorphous solid suspension) in carrier matrices or present spatial heterogeneity of composition .…”
Section: Amorphous Solid Dispersionmentioning
confidence: 99%